ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Using CRISPR to Modulate Gene Expression"
Episode Synopsis
Epicrispr Biotechnologies is using CRISPR to modulate the expression of disease-causing genes without making cuts to DNA. Its lead program is in development to treat FSHD, a genetic disorder that causes progressive weakness in the muscles of the face, shoulders, and upper arms. We spoke to Amber Salzman, CEO of Epicrispr, about how its one-and-done therapies work to target the epigenome, the company’s lead program in FSHD, and the broader applications for its therapeutic approach.
More episodes of the podcast RARECast
Turning a Rare Cancer into a Call to Action
24/12/2025
Finding Strength in Weakness
11/12/2025
Navigating Your Child’s Rare Disease
20/11/2025
In God we trust